{"id":"NCT02667275","sponsor":"Aclaris Therapeutics, Inc.","briefTitle":"A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis","officialTitle":"A Randomized, Double-Blind, Vehicle-Controlled, PArallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-01","primaryCompletion":"2016-10","completion":"2016-10","firstPosted":"2016-01-28","resultsPosted":"2017-11-13","lastUpdate":"2018-02-06"},"enrollment":487,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Seborrheic Keratosis"],"interventions":[{"type":"DRUG","name":"A-101 Solution","otherNames":[]},{"type":"OTHER","name":"Vehicle Solution","otherNames":[]}],"arms":[{"label":"A-101 Solution","type":"EXPERIMENTAL"},{"label":"Vehicle Solution","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, vehicle-controlled, parallel group study.","primaryOutcome":{"measure":"Proportion of Subjects With All Target Lesions Cleared According to Physician Lesion Assessment Scale","timeFrame":"Study day 106","effectByArm":[{"arm":"A-101 Solution","deltaMin":19,"sd":null},{"arm":"Vehicle Solution","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["30365590"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":244},"commonTop":["Sinusitis","Nasopharyngitis","Herpes Zoster"]}}